Treating cardiovascular disease involves a combination of lifestyle changes, medications, and in some cases, surgical procedures. The right approach depends on the type and severity of your condition, but for most people, treatment starts with the same foundation: modifying the risk factors that caused the disease in the first place. Even after a diagnosis, aggressive lifestyle changes and proper medication can slow progression, reduce the chance of a heart attack or stroke, and significantly extend your life.
Lifestyle Changes That Make the Biggest Difference
Diet and exercise aren’t just preventive measures. They’re active treatments. In the PREDIMED trial, which followed over 7,400 high-risk participants for five years, those eating a Mediterranean-style diet (rich in olive oil, nuts, fish, vegetables, and whole grains) had roughly 30% fewer heart attacks, strokes, and cardiovascular deaths compared to the control group. That’s a reduction comparable to some medications, achieved through food alone.
If you smoke, quitting is the single most impactful change you can make. Your risk of coronary heart disease drops sharply within one to two years of stopping, then continues to decline more gradually. Over time, stroke risk approaches that of someone who never smoked. No medication can replicate that benefit if you continue smoking.
For exercise, the numbers are more forgiving than most people expect. Resistance training for just 30 to 60 minutes per week is associated with the maximum risk reduction for both cardiovascular events and overall mortality. That can look like two sessions a week, each lasting 20 to 30 minutes, covering eight to ten exercises at moderate intensity. Aerobic exercise (walking, cycling, swimming) remains important too, with most guidelines recommending at least 150 minutes per week of moderate activity.
Medications for Blood Pressure and Cholesterol
Most people with cardiovascular disease will take at least one or two medications long-term. The three main drug classes used to control high blood pressure work in different ways: one group relaxes blood vessels by blocking a hormone that tightens them (ACE inhibitors or ARBs), another widens blood vessels directly (calcium channel blockers), and a third helps your kidneys flush out excess sodium and water (thiazide diuretics). Your doctor will typically start at a low dose and increase it over follow-up visits based on how your blood pressure responds.
Beta blockers, which slow your heart rate and reduce its workload, are commonly prescribed right after a heart attack. But they’re not considered a first-line choice for general blood pressure management, and many doctors transition patients off them once the acute recovery period is over.
Cholesterol-lowering medication, primarily statins, remains a cornerstone of treatment. The 2026 ACC/AHA guidelines set an LDL cholesterol target below 55 mg/dL for people at very high risk, defined as those who’ve had two or more major cardiovascular events (such as a heart attack plus a stroke) or one major event combined with additional risk factors like diabetes, smoking, or age 65 and older. For many patients, reaching that target requires adding a second medication alongside a statin.
When Statins Aren’t Enough
If your LDL remains too high on a maximum statin dose, your doctor may add ezetimibe, a pill that blocks cholesterol absorption in the gut. If that’s still not sufficient, a newer class of injectable drugs called PCSK9 inhibitors can bring LDL down dramatically. These work by preventing your liver from destroying its own LDL receptors, which are the structures that pull “bad” cholesterol out of your bloodstream. In clinical trials, PCSK9 inhibitors reduced LDL cholesterol by about 61 to 62%, bringing median levels from around 120 mg/dL down to 48 mg/dL. They’re typically reserved for people at very high risk who can’t reach their targets otherwise.
Newer Medications Changing Treatment
A class of drugs originally developed for type 2 diabetes, called SGLT2 inhibitors, has proven remarkably effective for heart failure. These medications work by helping your kidneys excrete excess sugar and fluid, which reduces the volume of blood your heart has to pump. In a large 2023 meta-analysis, SGLT2 inhibitors reduced the combined risk of heart failure hospitalization or cardiovascular death by 24% in patients with heart failure. They also cut cardiovascular death specifically by 16% in heart failure patients. One specific trial showed a 35% reduction in heart failure hospitalizations alone. These drugs are now a standard part of heart failure treatment regardless of whether you have diabetes.
Procedures: Stents vs. Bypass Surgery
When arteries are severely blocked, two main procedures can restore blood flow. Percutaneous coronary intervention (commonly called angioplasty with stenting) involves threading a thin tube through a blood vessel to the blockage, inflating a small balloon to open the artery, and leaving behind a mesh tube called a stent to keep it open. It’s minimally invasive, done through a small puncture in your wrist or groin, and recovery takes about a week.
Coronary artery bypass surgery (CABG) is a more involved open-heart operation where a surgeon uses a blood vessel from your chest, leg, or arm to create a detour around the blocked artery. Recovery typically takes six to twelve weeks. It’s generally recommended when you have multiple severely blocked arteries or blockages in locations that stents can’t easily reach.
The choice between the two isn’t always clear-cut. In patients with diabetes and multiple blocked arteries, five-year data shows no significant difference in death rates between stenting and bypass surgery. The decision often comes down to the number and location of blockages, your overall health, and whether you’re a good candidate for open-heart surgery.
Cardiac Rehabilitation After an Event
If you’ve had a heart attack, heart surgery, or been diagnosed with heart failure, cardiac rehabilitation is one of the most effective treatments available, yet it’s underused. The program has three phases. Phase 1 starts while you’re still in the hospital, focusing on gentle movement and education. Phase 2 is the structured outpatient program: most insurance plans, including Medicare, cover 36 sessions over 12 weeks, working out to three one-hour sessions per week. Each session combines supervised exercise with education on diet, stress management, and medication adherence. Phase 3 is the long-term maintenance you do on your own.
Cardiac rehab reduces the risk of dying from heart disease and significantly lowers the chance of being rehospitalized. Despite this, fewer than a third of eligible patients actually complete a program. If you’ve been offered a referral, it’s worth taking seriously.
Recognizing an Emergency
Living with cardiovascular disease means knowing the difference between stable symptoms and a medical emergency. Call 911 if you experience uncomfortable pressure, squeezing, or pain in the center of your chest lasting more than a few minutes, especially if it comes and goes. Pain spreading to your shoulders, neck, jaw, arms, or back alongside chest discomfort is a warning sign, as is chest pressure accompanied by lightheadedness, sweating, nausea, or sudden shortness of breath.
Women are more likely than men to experience less typical symptoms: nausea, vomiting, back pain, or jaw pain, sometimes without obvious chest pressure. Other signs that warrant emergency care include unexplained cold sweats, sudden paleness, palpitations, or a feeling of overwhelming anxiety or fatigue that comes on without explanation. These symptoms don’t always mean a heart attack, but they always warrant immediate evaluation.